COLLEGIUM PHARMACEUTICAL, INC
Collegium Pharmaceutical, Inc. (COLL: NASDAQ) operates as a specialty pharmaceutical company focused on developing and commercializing innovative pain management and other therapeutic solutions. The company maintains its corporate presence at www.collegiumpharma.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What COLLEGIUM PHARMACEUTICAL, INC does
In the company’s own words
Collegium Pharmaceutical, Inc. (COLL: NASDAQ) operates as a specialty pharmaceutical company focused on developing and commercializing innovative pain management and other therapeutic solutions. The company maintains its corporate presence at www.collegiumpharma.com.
The company's primary business centers on the development, manufacture, and distribution of pharmaceutical products addressing pain management and related therapeutic areas. Collegium's portfolio includes branded pharmaceutical products that leverage proprietary formulation technologies designed to enhance patient outcomes and reduce the potential for misuse. The company operates through its core pharmaceutical business, which encompasses both marketed products and pipeline candidates in various stages of development.
Collegium's commercial operations span multiple geographic markets, with particular focus on the United States pharmaceutical market. The company maintains manufacturing and distribution capabilities to support its product portfolio and serves healthcare providers, pharmacies, and patients through established distribution channels. The organization employs personnel across research and development, manufacturing, quality assurance, regulatory affairs, sales and marketing, and administrative functions necessary to support a specialty pharmaceutical enterprise.
The company's business model centers on identifying therapeutic opportunities where proprietary formulation technologies and specialized commercialization strategies can create differentiated products. Collegium's competitive positioning derives from its technical expertise in drug formulation, regulatory knowledge within the pain management and specialty pharmaceutical sectors, and established relationships with healthcare providers and distribution partners.
The company's capital structure reflects its operations as a publicly traded pharmaceutical enterprise, with financing arrangements supporting ongoing research and development activities, manufacturing operations, and commercial expansion. Collegium maintains a senior secured credit facility providing liquidity for operational needs and strategic initiatives. The company's strategic focus emphasizes sustainable growth through product development, market expansion of existing products, and potential acquisitions or licensing arrangements that align with its therapeutic expertise and commercial capabilities.
Company details
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Headquarters
- STOUGHTON, MA
- Fiscal year end
- December
- CIK
- 1267565
- SIC
- 2834
Financial performance, year by year
Fiscal 2015–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns COLLEGIUM PHARMACEUTICAL, INC — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · COLLEGIUM PHARMACEUTICAL, INC’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
COLLEGIUM PHARMACEUTICAL, INC’s bonds, as funds hold them
Funds report holding 1 issues of COLLEGIUM PHARMACEUTICAL, INC’s debt, $13.35M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 2.88%, maturing 2029 to 2029.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do COLLEGIUM PHARMACEUTICAL, INC and its peers compare on margins and cash generation over ten years?”
- “Where did five years of COLLEGIUM PHARMACEUTICAL, INC's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in COLLEGIUM PHARMACEUTICAL, INC's last four quarterly filings that the numbers alone won't show?”